ResMed Inc. RMD
NYSE · United States · Health Technology
$221.10-1.73 (-0.78%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q4 2026 | 2026-08-06 | 2.95 | 2.89 | +2.0% | $1.46B | +0.2% | -5.4%$224.03→$211.94 |
| Q1 2026 | 2026-04-30 | 2.86 | 2.79 | +2.5% | — | — | -3.3%$211.93→$205.02 |
| Q2 2026 | 2026-01-29 | 2.81 | 2.72 | +3.3% | — | — | +0.2%$257.72→$258.31 |
| Q3 2025 | 2025-10-30 | 2.55 | 2.49 | +2.4% | — | — | -2.7%$253.62→$246.88 |
| Q3 2025 | 2025-04-23 | 2.37 | 2.36 | +0.4% | — | — | — |
| Q2 2025 | 2025-01-30 | 2.43 | 2.31 | +5.2% | — | — | — |
| Q1 2025 | 2024-10-24 | 2.20 | 2.04 | +7.8% | — | — | — |
| Q3 2024 | 2024-04-25 | 2.13 | 1.91 | +11.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.